Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

CYTN:SW

1.28 CHF 0.01 0.79%

As of 11:33:32 ET on 04/17/2015.

Snapshot for Cytos Biotechnology AG (CYTN)

Open: 1.28 Day's Range: 1.21 - 1.28 Volume: 417,720
Previous Close: 1.27 52wk Range: 0.12 - 2.60 1-Yr Rtn: +611.11%

Stock Chart for CYTN

No chart data available.
  • CYTN:SW 1.28
  • 1D
  • 1M
  • 1Y
1.27
Interactive CYTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.8800
Est. PEG Ratio -
Market Cap (M CHF) 39.07
Shares Outstanding (M) 30.53
30 Day Average Volume 3,198,765
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTN

No data available

Company Profile & Key Executives for CYTN

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Frank HenneckeExec VP:Product DevDorothee KrumwiehVice President
More Company Profile & Key Executives for CYTN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil